Glucose/Ketone* level meters: StatStrip® and StatStrip Xpress®2

Besides studies presented to the FDA, 168 other independent studies over the past eight years — which include 53 critical care studies — have discovered no clinically significant interferences for StatStrip’s Glucose measurement technology.

This is a statement that cannot currently be made by any other glucose meter manufacturer. StatStrip and StatStrip Xpress2 are considered to be the most widely studied and proven glucose tests in the world. It has been tested to be suitable and effective for use across all professional healthcare and hospital settings, including critical care.

Only Bedside Glucose Meter to Measure and Correct Glucose Errors Caused by Abnormal Haematocrit Levels

Abnormal haematocrit levels are commonly found in hospitalpatients. Low haematocrit levels result in erroneously high glucose results while high haematocrit levels result in erroneously low glucose results.  Glucose meter errors of 40% or more have been reported due to the effects of haematocrit. These errors can cause either under-or over-dosing of insulin, resulting in unsafe levels of hyperglycemia or hypoglycemia.

Only Glucose Meter to Measure and Correct Errors Caused by Electrochemical Interferences

StatStrip’s Multi-Well technology employs a patented, additional interference test well to measure electrochemical interferences and correct for their effect.  Among the electrochemical interferences eliminated are paracetamol (acetaminophen), ascorbic acid (vitamin C), uric acid, oxygen, and bilirubin.

Blood ketone testing should be performed whenever glucose exceeds 14 mmol/L (250 mg/dL)

The American Diabetes Association (ADA), the European Society for Paediatric Endocrinology, the Canadian Diabetes Association and Diabetes UK suggest that blood ketone testing should be carried out whenever glucose surpasses 14 to 17 mmol/L for quickly detecting or preventing diabetic ketoacidosis (DKA).

StatStrip Glucose/Ketone* measures blood beta-hydroxybutyrate, the preferred ketone for diagnosing ketoacidosis

As per Diabetes UK, ADA, European Society for Paediatric Endocrinology and others, blood ketone testing techniques that measure beta-hydroxybutyrate — the predominant ketone body in DKA — are recommended in the place of urine ketone testing for diagnosing and tracking ketoacidosis.

Blood ketone is more accurate than urine ketone testing

Blood beta-hydroxyburyrate testing denotes the status of the patient during the test, while urine might have been in the bladder for many hours.

Moreover, urine testing can generate false positive or negative results because of highly acidic urine, highly colored urine, exposure of the urine test strips to air for extended periods, drugs like the ACE inhibitor captopril or high doses of vitamin C.

Small, 1.2 Microliter Capillary, Venous, Arterial, or Neonatal Samples

A 1.2 microliter sample size results in less pain for the patient and sampling from central venous or arterial lines, eliminates the fingerstick. End-filled capillary action test strips are designed for fast, easy sample uptake.

Fast, 6-Second Glucose Results, 10-Second Ketone Results

The time spent by point-of-care personnel to perform frequent bedside testing is reduced by the fast analysis time and elimination of the calibration code step.

Entry of Manual, Off-line Tests

StatStrip supports touch screen entry of an unlimited number of user-defined off-line tests which can be transmitted to the     LIS/EMR via Nova middleware. These results can be quantitative or qualitative, numeric input, or free text. Test and control ranges, and lot number may be input foreach test.

Wireless meter connectivity to LIS/HIS with StatStrip Glucose/Ketone*

The StatStrip Glucose/Ketone Hospital Meter System provides bidirectional wireless connectivity to hospital HIS or LIS with full security to safeguard patient data.

  • Wireless connectivity can send results of the patient directly from the bedside, thus mitigating the necessity to bring the meter to a fixed location for data transmission and meter docking.
  • Dual-band wireless connectivity offers full security and encryption to guarantee that patient data is maintained with no compromise.
  • Wireless connectivity helps save time for the caregiver and enables quicker charting of findings and clinical decision-making to enhance patient care.
  • All wireless devices make use of the industry-standard POCT1-A2 data format and are consistent with a choice of middleware collaborators.
  • Nova at present provides a complete range of StatStrip Glucose/Ketone wireless connectivity capabilities, inclusive of wireless docking stations, wireless carrying cases and wireless meters.

* Ketone testing is not available with StatStrip meters in the U.S. but Glucose testing is available


  1. Vanelli et al. (2003). Cost effectiveness of the direct measurement of 3-β-hydroxybutyrate in the management of diabetic ketoacidosis in children [Letter to the editor]. Diabetes Care, 26(3), 959.
  2. Noyes et al. (2007). Hydroxybutyrate near-patient testing to evaluate a new end-point for intravenous insulin therapy in the treatment of diabetic ketoacidosis in children. Pediatric Diabetes, 8, 150-156.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.